Open-label placebo reduces fatigue in cancer survivors: a randomized trial.
Eric S ZhouKathryn T HallAlexis L MichaudJaime E BlackmonAnn H PartridgeChristopher J RecklitisPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)
Results demonstrate that even when administered openly, placebos improve CRF in cancer survivors and dopaminergic systems may be associated with this response. This novel research has meaningful implications for the use of OLP in symptom management for cancer survivors.